{"id":20980,"date":"2022-09-26T17:41:06","date_gmt":"2022-09-26T15:41:06","guid":{"rendered":"https:\/\/test.lab.cor2ed.com\/cms\/?post_type=experts&#038;p=20980"},"modified":"2023-06-14T12:31:37","modified_gmt":"2023-06-14T10:31:37","slug":"dr-nataliya-uboha","status":"publish","type":"experts","link":"https:\/\/test.lab.cor2ed.com\/cms\/experts\/dr-nataliya-uboha\/","title":{"rendered":"Dr Nataliya Uboha"},"content":{"rendered":"<p>Dr Nataliya Uboha is an Associate Professor at the University of Wisconsin, Department of Medicine, Division of Hematology and Oncology and a member of Carbone Cancer Center (UWCCC). Her clinical and research activities focus on upper GI cancers. She has extensive clinical trial experience, with a particular emphasis on phase 1 and biomarker based clinical studies. She is a Faculty Leader for the Cancer Therapy Discovery &amp; Development (Phase I) Program at UWCCC. She is a co-leader and founder of the Basket Disease Oriented Team at UWCCC, which has a specific focus on biomarker based trials across disease types. Dr Uboha has a number of regional and national leadership roles. She serves on the board of Wisconsin Association of Hematology and Oncology. She is a co-chair for the GI Cancer Research Group in Big 10 Cancer Research Consortium. She chairs the Upper GI working group at ECOG-ACRIN and serves on the National Cancer Institute Upper GI Taskforce as an ECOG representative.<\/p>\n","protected":false},"author":{"id":116,"first_name":"Louise","last_name":"Handbury","nickname":"louise.handbury@cor2ed.com","email":"louise.handbury@cor2ed.com"},"featured_media":20989,"menu_order":5,"template":"","groups":[],"class_list":["post-20980","experts","type-experts","status-publish","has-post-thumbnail","hentry"],"expert_info_prefix":"Dr","expert_info_first-name":"Nataliya","expert_info_last-name":"Uboha","expert_info_institution":"University of Wisconsin","expert_info_country":"US","expert_info_specialization":"Medical Oncologist","expert_info_map-code":"","expert_info_disclosures":"<p>Consulting: QED, Taiho Inc., Incyte, AstraZeneca, Pfizer, Boston Gene, Helsinn<br \/>Research Funding: Taiho Inc, Ipsen, EMD Serono<br \/>Long position holdings: Natera, Exact Sciences<\/p>","expert_info_linkedin":"","expert_info_twitter":"","expert_info_instagram":"","expert_info_facebook":"","_links":{"self":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/20980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts"}],"about":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/types\/experts"}],"version-history":[{"count":3,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/20980\/revisions"}],"predecessor-version":[{"id":88892,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/20980\/revisions\/88892"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/media\/20989"}],"wp:attachment":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/media?parent=20980"}],"wp:term":[{"taxonomy":"groups","embeddable":true,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/groups?post=20980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}